NZ619290A - Anthelmintic formulation - Google Patents
Anthelmintic formulationInfo
- Publication number
- NZ619290A NZ619290A NZ61929010A NZ61929010A NZ619290A NZ 619290 A NZ619290 A NZ 619290A NZ 61929010 A NZ61929010 A NZ 61929010A NZ 61929010 A NZ61929010 A NZ 61929010A NZ 619290 A NZ619290 A NZ 619290A
- Authority
- NZ
- New Zealand
- Prior art keywords
- anthelmintic
- group
- composition
- water
- agent
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 3
- 230000000507 anthelmentic effect Effects 0.000 title abstract 2
- 238000009472 formulation Methods 0.000 title 1
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 abstract 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 abstract 3
- 229940124339 anthelmintic agent Drugs 0.000 abstract 3
- 239000000921 anthelmintic agent Substances 0.000 abstract 3
- 239000005660 Abamectin Substances 0.000 abstract 2
- 239000002904 solvent Substances 0.000 abstract 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 2
- YWDWYOALXURQPZ-CYBMUJFWSA-N 2-methyl-n-[3-[(6s)-2,3,5,6-tetrahydroimidazo[2,1-b][1,3]thiazol-6-yl]phenyl]propanamide Chemical compound CC(C)C(=O)NC1=CC=CC([C@@H]2N=C3SCCN3C2)=C1 YWDWYOALXURQPZ-CYBMUJFWSA-N 0.000 abstract 1
- AZSNMRSAGSSBNP-UHFFFAOYSA-N 22,23-dihydroavermectin B1a Natural products C1CC(C)C(C(C)CC)OC21OC(CC=C(C)C(OC1OC(C)C(OC3OC(C)C(O)C(OC)C3)C(OC)C1)C(C)C=CC=C1C3(C(C(=O)O4)C=C(C)C(O)C3OC1)O)CC4C2 AZSNMRSAGSSBNP-UHFFFAOYSA-N 0.000 abstract 1
- UMZCLZPXPCNKML-UHFFFAOYSA-N 2h-imidazo[4,5-d][1,3]thiazole Chemical group C1=NC2=NCSC2=N1 UMZCLZPXPCNKML-UHFFFAOYSA-N 0.000 abstract 1
- IBSREHMXUMOFBB-JFUDTMANSA-N 5u8924t11h Chemical compound O1[C@@H](C)[C@H](O)[C@@H](OC)C[C@@H]1O[C@@H]1[C@@H](OC)C[C@H](O[C@@H]2C(=C/C[C@@H]3C[C@@H](C[C@@]4(O3)C=C[C@H](C)[C@@H](C(C)C)O4)OC(=O)[C@@H]3C=C(C)[C@@H](O)[C@H]4OC\C([C@@]34O)=C/C=C/[C@@H]2C)/C)O[C@H]1C.C1=C[C@H](C)[C@@H]([C@@H](C)CC)O[C@]11O[C@H](C\C=C(C)\[C@@H](O[C@@H]2O[C@@H](C)[C@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](OC)C3)[C@@H](OC)C2)[C@@H](C)\C=C\C=C/2[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\2)O)C[C@H]4C1 IBSREHMXUMOFBB-JFUDTMANSA-N 0.000 abstract 1
- SPBDXSGPUHCETR-JFUDTMANSA-N 8883yp2r6d Chemical compound O1[C@@H](C)[C@H](O)[C@@H](OC)C[C@@H]1O[C@@H]1[C@@H](OC)C[C@H](O[C@@H]2C(=C/C[C@@H]3C[C@@H](C[C@@]4(O[C@@H]([C@@H](C)CC4)C(C)C)O3)OC(=O)[C@@H]3C=C(C)[C@@H](O)[C@H]4OC\C([C@@]34O)=C/C=C/[C@@H]2C)/C)O[C@H]1C.C1C[C@H](C)[C@@H]([C@@H](C)CC)O[C@@]21O[C@H](C\C=C(C)\[C@@H](O[C@@H]1O[C@@H](C)[C@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](OC)C3)[C@@H](OC)C1)[C@@H](C)\C=C\C=C/1[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\1)O)C[C@H]4C2 SPBDXSGPUHCETR-JFUDTMANSA-N 0.000 abstract 1
- HLFSDGLLUJUHTE-SNVBAGLBSA-N Levamisole Chemical compound C1([C@H]2CN3CCSC3=N2)=CC=CC=C1 HLFSDGLLUJUHTE-SNVBAGLBSA-N 0.000 abstract 1
- AQXXZDYPVDOQEE-MXDQRGINSA-N Pyrantel pamoate Chemical compound CN1CCCN=C1\C=C\C1=CC=CS1.C1=CC=C2C(CC=3C4=CC=CC=C4C=C(C=3O)C(=O)O)=C(O)C(C(O)=O)=CC2=C1 AQXXZDYPVDOQEE-MXDQRGINSA-N 0.000 abstract 1
- 229950008167 abamectin Drugs 0.000 abstract 1
- RRZXIRBKKLTSOM-XPNPUAGNSA-N avermectin B1a Chemical compound C1=C[C@H](C)[C@@H]([C@@H](C)CC)O[C@]11O[C@H](C\C=C(C)\[C@@H](O[C@@H]2O[C@@H](C)[C@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](OC)C3)[C@@H](OC)C2)[C@@H](C)\C=C\C=C/2[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\2)O)C[C@H]4C1 RRZXIRBKKLTSOM-XPNPUAGNSA-N 0.000 abstract 1
- 235000019445 benzyl alcohol Nutrition 0.000 abstract 1
- 230000003139 buffering effect Effects 0.000 abstract 1
- 229950000536 butamisole Drugs 0.000 abstract 1
- QLFZZSKTJWDQOS-YDBLARSUSA-N doramectin Chemical compound O1[C@@H](C)[C@H](O)[C@@H](OC)C[C@@H]1O[C@@H]1[C@@H](OC)C[C@H](O[C@@H]2C(=C/C[C@@H]3C[C@@H](C[C@@]4(O3)C=C[C@H](C)[C@@H](C3CCCCC3)O4)OC(=O)[C@@H]3C=C(C)[C@@H](O)[C@H]4OC\C([C@@]34O)=C/C=C/[C@@H]2C)/C)O[C@H]1C QLFZZSKTJWDQOS-YDBLARSUSA-N 0.000 abstract 1
- 229960003997 doramectin Drugs 0.000 abstract 1
- 229960002418 ivermectin Drugs 0.000 abstract 1
- 150000002596 lactones Chemical class 0.000 abstract 1
- 229960001614 levamisole Drugs 0.000 abstract 1
- FXWHFKOXMBTCMP-WMEDONTMSA-N milbemycin Natural products COC1C2OCC3=C/C=C/C(C)CC(=CCC4CC(CC5(O4)OC(C)C(C)C(OC(=O)C(C)CC(C)C)C5O)OC(=O)C(C=C1C)C23O)C FXWHFKOXMBTCMP-WMEDONTMSA-N 0.000 abstract 1
- YZBLFMPOMVTDJY-CBYMMZEQSA-N moxidectin Chemical compound O1[C@H](C(\C)=C\C(C)C)[C@@H](C)C(=N/OC)\C[C@@]11O[C@H](C\C=C(C)\C[C@@H](C)\C=C\C=C/2[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\2)O)C[C@H]4C1 YZBLFMPOMVTDJY-CBYMMZEQSA-N 0.000 abstract 1
- 229960004816 moxidectin Drugs 0.000 abstract 1
- 229920001223 polyethylene glycol Polymers 0.000 abstract 1
- 229960000996 pyrantel pamoate Drugs 0.000 abstract 1
- 239000004094 surface-active agent Substances 0.000 abstract 1
- UWHCKJMYHZGTIT-UHFFFAOYSA-N tetraethylene glycol Chemical compound OCCOCCOCCOCCO UWHCKJMYHZGTIT-UHFFFAOYSA-N 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
The disclosure relates to a stable anthelmintic composition in the form of a micellar solution, comprising an anthelmintically effective amount of at least two anthelmintic agents, wherein one anthelmintic agent is a macrocyclic lactone selected from the group consisting of: abamectin, ivermectin, doramectin, moxidectin, milbemycin and/or avermectin, and the other anthelmintic agent is an imidazothiazole selected from the group consisting of: levamisole, pyrantel pamoate and butamisole; at least one surfactant; a solvent system comprising water and one or more water miscible solvent(s) selected from the group consisting of one or more polyethylene glycols, tetraglycol, ethanol, benzyl alcohol and propylene glycol; and a buffering system to adjust the pH of the composition to a range of about 5 to 5.5.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NZ58980310 | 2010-12-08 | ||
| NZ60123610 | 2010-12-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ619290A true NZ619290A (en) | 2015-04-24 |
Family
ID=52876043
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ61929010A NZ619290A (en) | 2010-12-08 | 2010-12-08 | Anthelmintic formulation |
Country Status (1)
| Country | Link |
|---|---|
| NZ (1) | NZ619290A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2022077087A1 (en) * | 2020-10-16 | 2022-04-21 | Ipanema Industria De Produtos Veterinarios Ltda | Microsuspension against parasites and method for obtaining same |
-
2010
- 2010-12-08 NZ NZ61929010A patent/NZ619290A/en unknown
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2022077087A1 (en) * | 2020-10-16 | 2022-04-21 | Ipanema Industria De Produtos Veterinarios Ltda | Microsuspension against parasites and method for obtaining same |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0409185A (en) | topical anthelmintic veterinary formulations | |
| PE20001319A1 (en) | ANTIPARASITIC FORMULATIONS OF AVERMECTINS OR MILBEMYCINS | |
| PE20011289A1 (en) | ANTIHELMINE COMPOSITIONS INCLUDING MACROCYCLIC AND SPIRODIOXEPINOINDOLES LACTONES | |
| UA108641C2 (en) | PARASITICID COMPOSITION CONTAINING FOUR ACTIVE AGENTS AND METHOD OF APPLICATION | |
| SG156624A1 (en) | Organo-gel formulations for therapeutic applications | |
| BRPI0507653A (en) | imidazopyridine derivatives and imidazopyridine pharmaceutical formulation comprising the same and use | |
| CL2013000715A1 (en) | Pharmaceutical composition comprising (3s, 11ar) -n - [(2,4-difluorophenyl) methyl] -2,3,5,7,11,11a-hexahydro-6-hydroxy-3-methyl-5,7-dioxo -oxazolo [3,2-a] pyrido [1,2-d] pyrazin-8-carboxamide and a polysorbate and polyethylene glycol surfactant system; treatment method; and its use to treat or prevent a hiv infection. | |
| WO2011049713A3 (en) | Stabilized glucagon solutions | |
| JP2011503140A5 (en) | ||
| AR079409A1 (en) | GRANULATED ANTIHELMINTIC PREPARATIONS AND SUNINISTER SYSTEMS | |
| RU2016140272A (en) | Stable veterinary anthelmintic compositions | |
| JP2009518400A5 (en) | ||
| HK1116047A1 (en) | Anthelmintic composition | |
| RU2015122162A (en) | Transdermal Antiparasitic Compositions | |
| EP1066854A3 (en) | Anthelmintic compositions containing combinations of avermectins or milbemycins with bis-aryl compounds | |
| NZ619290A (en) | Anthelmintic formulation | |
| ES2846820T3 (en) | Composition of macrocyclic lactones, levamisole, an amino sugar and an additional antiparasitic agent | |
| NZ584585A (en) | Injectable formulations comprising a macrocylclic lactone, benzyl alcohol and a biodegradable polyester | |
| CA2622713A1 (en) | Anthelmintic formulations | |
| BRPI0608083A2 (en) | composition comprising ocaperidone | |
| US8901090B2 (en) | Method of treating otitis externa using macrocyclic lactone compound | |
| NZ605982A (en) | Compositions containing flavones and anthelmintics | |
| NZ705890A (en) | Drenching platform or system, consumables thereof and related aspects | |
| RU2018135676A (en) | UNION OF THE FAMILY AVERMECTIN OR THE MILBEMYCIN FAMILY FOR THE TREATMENT AND / OR PREVENTION OF ATOPIC DERMATITIS | |
| Bustos | Biopharmaceutical study of therapeutic efficacy of nanostructured formulations |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ERR | Error or correction |
Free format text: THE OWNER HAS BEEN CORRECTED TO 3012472, JUROX PTY LTD, 85 GARDINERS ROAD, RUTHERFORD, NEW SOUTH WALES 2320, AU Effective date: 20150408 |
|
| PSEA | Patent sealed | ||
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 08 DEC 2017 BY FB RICE Effective date: 20150728 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 08 DEC 2018 BY CPA GLOBAL Effective date: 20171026 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 08 DEC 2019 BY CPA GLOBAL Effective date: 20181025 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 08 DEC 2020 BY CPA GLOBAL Effective date: 20191024 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 08 DEC 2021 BY CPA GLOBAL Effective date: 20201022 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 08 DEC 2022 BY CPA GLOBAL Effective date: 20211022 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 08 DEC 2023 BY CPA GLOBAL Effective date: 20221027 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 08 DEC 2024 BY THOMSON REUTERS Effective date: 20231101 |
|
| ASS | Change of ownership |
Owner name: ZOETIS SERVICES LLC, US Effective date: 20240308 |